Analiza is a leading provider of physicochemical services to the pharmaceutical industry. Our high throughput work cells provide us with the ability to give you highly accurate and reproducible data at a fraction of the typical CRO costs. Our analytical services include: Thermodynamic or Kinetic Solubility, Log D, pKA (multiplexed CE), Crystallinity Assessment (XRD), Blood Brain Barrier, Concentration Check, Dose Validation and most recently, our proprietary Fragment Based Screening assay. We use miniaturized gold standard shake flask methods, no predicting, no guessing, just high quality data, early in the discovery process.

ANALIZA, Inc. is a privately held corporation dedicated to discovering, developing, and commercializing new technologies for the life sciences. ANALIZA provides integrated solutions to key applications in the pharmaceutical, biotechnology and diagnostics industries.
|
NEWS & EVENTS
Analiza expands services to include pKa and XRD
Analiza selected as one of Top 25 cool tech places to work by Cleveland Magazine
MARM 2008
6th EGA Symposium on Biosimilar Medicines
London April 24th - 25th
AAPS
November 16-20, 2008
BioProcess International
September 23 - 26, 2008
Analiza major sponsor for new APS Pharmaceutical Poster website
Biosimilars 2007
12/6-12/7
Talk #1 - New and established analytical tools for demonstrating comparability
Talk #2 - Low-Cost Process Purification Technology For Enabling Competitive Biosimilars
AnalizaDx receives 2007 Innovation Award
11/14/07
Analiza presenting three posters at the upcoming AAPS conference
11/11-15/07
AAPS
11/11-15/07
In Vitro Phsychem Techniques and Assays
9/27/07
Screening and Ion Channel Targets
9/10-11/07
International Conference on Biopartitioning and Purification
6/17-20/07
Genetic Engineering News
6/15/07
|